We are live on ! Find out more
Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT) Portfolio holdings

AUM $89.9B
1-Year Est. Return 20.22%
This Fund
S&P 500
This Quarter Est. Return
+2.75%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
AUM
$27.5B
AUM Growth
+$4.26B
Cap. Flow
+$26B
Cap. Flow %
94.62%
Top 10 Hldgs %
8.07%
Holding
3,226
New
745
Increased
868
Reduced
662
Closed
894

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$151M
2
JNJ icon
Johnson & Johnson
JNJ
+$149M
3
COP icon
ConocoPhillips
COP
+$142M
4
DHR icon
Danaher
DHR
+$112M
5
SPGI icon
S&P Global
SPGI
+$106M

Sector Composition

Rank Sector Weight
1 Technology 21.09%
2 Consumer Discretionary 14.55%
3 Financials 12.04%
4 Healthcare 11.32%
5 Industrials 10.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NKTR icon
1751
Nektar Therapeutics
NKTR
$2.41B
$218K ﹤0.01%
+25,227
New +$269K
ITOS
1752
DELISTED
iTeos Therapeutics
ITOS
$217K ﹤0.01%
+16,413
New +$234K
SGHT icon
1753
Sight Sciences
SGHT
$279M
$215K ﹤0.01%
26,006
+1,584
+6% +$14.3K
SOND
1754
DELISTED
Sonder
SOND
$215K ﹤0.01%
+20,267
New +$220K
FFLG icon
1755
Fidelity Fundamental Large Cap Growth ETF
FFLG
$576M
$213K ﹤0.01%
5,364
+4,608
+610% +$71K
AFT
1756
DELISTED
Apollo Senior Floating Rate Fund Inc.
AFT
$212K ﹤0.01%
16,457
TOWN icon
1757
Towne Bank
TOWN
$3.45B
$212K ﹤0.01%
+9,111
New +$219K
REAL icon
1758
The RealReal
REAL
$1.4B
$212K ﹤0.01%
+95,276
New +$130K
SPNS
1759
DELISTED
Sapiens International
SPNS
$211K ﹤0.01%
7,939
-6,678
-46% -$158K
CCCC icon
1760
C4 Therapeutics
CCCC
$397M
$211K ﹤0.01%
76,782
+47,094
+159% +$151K
PTMC icon
1761
Pacer Trendpilot US Mid Cap ETF
PTMC
$395M
$211K ﹤0.01%
+4,407
New +$141K
NPK icon
1762
National Presto Industries
NPK
$896M
$211K ﹤0.01%
+2,879
New +$212K
RLAY icon
1763
Relay Therapeutics
RLAY
$4.06B
$211K ﹤0.01%
16,777
-23,302
-58% -$290K
MTUM icon
1764
iShares MSCI USA Momentum Factor ETF
MTUM
$25.2B
$210K ﹤0.01%
8,289
-8,517
-51% -$1.2M
RXST icon
1765
RxSight
RXST
$233M
$210K ﹤0.01%
+7,297
New +$162K
IQLT icon
1766
iShares MSCI Intl Quality Factor ETF
IQLT
$13.6B
$208K ﹤0.01%
+2,131
New +$76K
INFL icon
1767
Horizon Kinetics Inflation Beneficiaries ETF
INFL
$1.49B
$207K ﹤0.01%
+6,761
New +$207K
JOBY.WS icon
1768
Joby Aviation Warrants
JOBY.WS
$206K ﹤0.01%
77,764
ANGI icon
1769
Angi Inc
ANGI
$240M
$205K ﹤0.01%
6,199
-6,706
-52% -$188K
BOC icon
1770
Boston Omaha
BOC
$434M
$203K ﹤0.01%
+10,800
New +$219K
IVOO icon
1771
Vanguard S&P Mid-Cap 400 ETF
IVOO
$3.74B
$202K ﹤0.01%
+794
New +$66.9K
VCSA
1772
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
$202K ﹤0.01%
14,856
+9,325
+169% +$140K
NAT icon
1773
Nordic American Tanker
NAT
$1.37B
$201K ﹤0.01%
54,783
-32,808
-37% -$119K
CLFD icon
1774
Clearfield
CLFD
$436M
$200K ﹤0.01%
4,234
-41,376
-91% -$1.77M
PVBC
1775
DELISTED
Provident Bancorp
PVBC
$200K ﹤0.01%
+24,140
New +$182K

Similar funds

Qube Research & Technologies (QRT)'s Q2 2023 Portfolio in Review

As of Q2 2023, Qube Research & Technologies (QRT) held 3,226 positions worth $27.5B, up 18% from $23.2B the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.

Qube Research & Technologies (QRT) deployed $26B of net new capital in Q2 2023, opening 745 new positions and adding to 868 existing holdings. Its largest new stake was Microsoft: 704,526 shares worth $240M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Cigna, an estimated $151M trimmed.

  • Qube Research & Technologies (QRT)'s largest Q2 2023 buy was Microsoft: 704,526 shares worth $240M.
  • Qube Research & Technologies (QRT) added most to Thermo Fisher Scientific in Q2 2023, an estimated $192M increase.
  • Qube Research & Technologies (QRT)'s biggest Q2 2023 reduction was Cigna, cutting an estimated $151M.
  • Qube Research & Technologies (QRT) fully exited ConocoPhillips in Q2 2023, selling an estimated $142M.
  • Qube Research & Technologies (QRT)'s ten largest holdings make up 8.1% of its $27.5B portfolio in Q2 2023.
  • Qube Research & Technologies (QRT) opened 745 new positions and closed 894 in Q2 2023.
  • Qube Research & Technologies (QRT)'s portfolio value rose 18% quarter-over-quarter to $27.5B.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2023, filed 14 Aug 2023.